By
Joseph P. Porter
Published: Feb. 5, 2014, 11:09 a.m.·
Tags:
Pharma industry,
Research and development
On January 31, 2014, a report was released that AstraZeneca Group plc ADR (AZN) (hereafter, "AZ") announced that it was closing its Avishkar Research & Development facility in Bangalore, India. The closing, which will affect 168 employees, is part of an effort by the British pharmaceutical firm to refocus its resources in R&D. The closing is to take place later this year.1
Read More →
